For research use only. Not for therapeutic Use.
Cudetaxestat (BLD-0409) is a potent and orally active autotaxin (ATX) inhibitor[1].
| Catalog Number | I045114 |
| CAS Number | 1782070-21-6 |
| Synonyms | 3-[2,6-dichloro-7-fluoro-1-(1-propylpyrazol-4-yl)indol-3-yl]sulfanyl-2-fluorobenzoic acid |
| Molecular Formula | C21H15Cl2F2N3O2S |
| Purity | ≥95% |
| InChI | InChI=1S/C21H15Cl2F2N3O2S/c1-2-8-27-10-11(9-26-27)28-18-13(6-7-14(22)17(18)25)19(20(28)23)31-15-5-3-4-12(16(15)24)21(29)30/h3-7,9-10H,2,8H2,1H3,(H,29,30) |
| InChIKey | NMDFAQXLJQRHMS-UHFFFAOYSA-N |
| SMILES | CCCN1C=C(C=N1)N2C3=C(C=CC(=C3F)Cl)C(=C2Cl)SC4=CC=CC(=C4F)C(=O)O |
| Reference | [1]. Tan Z, et al. An updated patent review of autotaxin inhibitors (2017-present). Expert Opin Ther Pat. 2021;31(5):421-434. |
